2005
DOI: 10.1007/s00381-005-1199-0
|View full text |Cite
|
Sign up to set email alerts
|

Primary giant congential infantile fibrosarcoma of the scalp

Abstract: The pathology and management of primary scalp fibrosarcoma is discussed, and the relevant literature is briefly reviewed.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2014
2014
2019
2019

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 10 publications
0
4
0
Order By: Relevance
“…Another group of lesions with rare cranial occurrence and similar external features are sarcomas [3,9]. Microscopically, sarcomas and hemangiomas have a significant difference in appearance.…”
Section: Discussionmentioning
confidence: 97%
“…Another group of lesions with rare cranial occurrence and similar external features are sarcomas [3,9]. Microscopically, sarcomas and hemangiomas have a significant difference in appearance.…”
Section: Discussionmentioning
confidence: 97%
“…Fibrosarcoma arising from the soft tissue in the skull is an extremely rare condition with only a few cases reported in the literature. [1][2][3] The several histologic subtypes of this malignant disease include sclerosing epithelioid fibrosar-coma, dermatofibrosarcoma, radiation-induced sarcoma, primary congenital infantile fibrosarcoma, and myxoinflammatory fibroblastic sarcoma. 4 All these are rarely encountered in the scalp and even less often in the bones of the skull.…”
Section: Discussionmentioning
confidence: 99%
“…4 Wide surgical excision is the mainstay of treatment, although it is also known to be a chemosensitive tumor and as such adjuvant or neoadjuvant chemotherapy is also employed in its management, especially where a wide excision is difficult to achieve. 12 The prognosis is poor and most of the patients either experience local recurrences or distant metastases and die of the disease. Mean survival time for those dying from the tumor has been reported to be 2.4 years, and a 5-year survival period remains a significant indicator of cure.…”
Section: Discussionmentioning
confidence: 99%